One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…

James Head Biography and Net Worth

CFO of MultiPlan

Jim has served as the Executive Vice President and Chief Financial Officer of MultiPlan Corporation since November, 2021. Prior to being appointed to his current role he served as a Partner at BDT & Company, LLC from 2016 until March 2021 and, prior to that, worked at Morgan Stanley for 22 years where he held various executive leadership roles, including Co-Head of the Mergers, Acquisitions and Restructuring Group, Americas from 2013 to 2016; Co-Head of the Financial Institutions M&A Group, Americas from 2008 to 2013; and Managing Director from 2003 to 2016.

How old is James M. Head?: Mr. Head is currently 58 years old. There are 5 older executives and no younger executives at MultiPlan. The oldest executive at MultiPlan is Mr. Dale A. White, Executive Chair, who is 68 years old. Learn More on James M. Head's age.
How do I contact James M. Head?: The corporate mailing address for Mr. Head and other MultiPlan executives is , , . MultiPlan can also be reached via phone at 212-780-2000 and via email at [email protected]. Learn More on James M. Head's contact information.
Has James M. Head been buying or selling shares of MultiPlan?: James M. Head has not been actively trading shares of MultiPlan during the past quarter. Most recently, on Monday, November 29th, James M. Head bought 300,000 shares of MultiPlan stock. The stock was acquired at an average cost of $4.34 per share, with a total value of $1,302,000.00. Learn More on James M. Head's trading history.
Who are MultiPlan's active insiders?: MultiPlan's insider roster includes Glenn August (Director), Anthony Colaluca, Jr (Director), Paul Galant (Insider), James Head (CFO), Julie Klapstein (Director), and Michael Klein (Director). Learn More on MultiPlan's active insiders.

James M. Head Insider Trading History at MultiPlan

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/29/2021	Buy	300,000	$4.34	$1,302,000.00

James M. Head Buying and Selling Activity at MultiPlan

MultiPlan Company Overview

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.

Today's Range

Now: $0.57

$0.54

$0.59

50 Day Range

MA: $0.87

$0.55

$1.23

2 Week Range

Now: $0.57

$0.54

$2.29

Volume

1,976,931 shs

Average Volume

1,650,017 shs

Market Capitalization

$367.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

The World's First "$20 Trillion Drug?"

From Behind the Markets | Ad

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>